FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to the substituted phenylpyrimidine compounds of the formula (I) where R1 means NH2, N-alkylamino-, N,N-dialkylamino-groups; R2 means NH2; R3 means trifluoromethyl- or CH2X where X means C1-C6-alkyl, phenoxy-, benzylhydroxy-, hydroxy- or halogen atom; R4 and R5 each means halogen; R6-R8 each means hydrogen, and its pharmaceutically acceptable acid-additive salts that are power inhibitors of exciting amino acid, glutamate. Method of synthesis of compounds of the formula (I) involves interaction of compounds of the formula (III): R1C(=NH)NH2 with compounds of the formula (II) and (V) . The proposed composition contains an effective amount of compound of the formula (I) or its pharmaceutically acceptable salt as an inhibitor of glutamate release. The synthesized compounds can be used for treatment or prevention of some damages in central nervous system involving cerebral ischemic disorder and epilepsy. EFFECT: improved method of synthesis, enhanced effectiveness of composition. 9 cl, 2 tbl, 4 ex
Title |
Year |
Author |
Number |
METHOD OF PREPARING SUBSTITUTED 5-ARYL-PYRIMIDINES |
1991 |
- Majkl Dzhon Lich[Gb]
- Mal'Kol'M Stjuart Nobbz[Gb]
- Ramachandran Ijer[Gb]
- Klajv Leonard Jits[Gb]
- Filip Alan Skoun[Gb]
|
RU2091374C1 |
METHOD OF SYNTHESIS OF 4-AMINO-2-(4-METHYLPIPERAZINE-1-YL)-5-(2,3,5-TRICHLOROPHENYL)- -PYRIMIDINE OR ITS ACID ADDITIVE SALT |
1989 |
- Ehlistehjr Ehjnsli Miller[Gb]
- Mal'Kol'M Stjuart Nobbz[Gb]
- Richard Martin Gajd[Gb]
- Majkl Dzhon Lich[Gb]
|
RU2079493C1 |
ENANTIOMERIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1992 |
|
RU2091386C1 |
METHOD OF SYNTHESIS OF ENANTIOMERIC COMPOUNDS OR THEIR DERIVATIVES |
1990 |
|
RU2068849C1 |
4-AMINO-2-(4-METHYLPIPERAZINE-1-YL)-5-(2,3,5-TRICHLOROPHENYL)- -PYRIMIDINE AND ITS SALTS OF ACID ADDITION, METHODS OF THEIR SYNTHESIS (VARIANTS) AND PHARMACEUTICAL COMPOSITION |
1989 |
- Miller Ehlistehjr Ehjnsli
- Nobbz Mal'Kol'M Stjuart
- Gajd Richard Martin
- Lich Majkl Dzhon
|
RU2171256C2 |
METHOD OF PRODUCING TRIAZINE OR ACID-ADDITIVE SALTS THEREOF |
0 |
- Dzheffri Allan
- Alistejr Ajnsli Miller
- David Alan Sojer
|
SU1371500A3 |
METHOD OF PRODUCING BICYCLIC COMPOUNDS OR ADDITIVE SALTS OF HYDROCHLORIC ACID THEREOF |
0 |
|
SU1384200A3 |
N,N-DIMETHYL-2-(5-(2-OXO-1,3-OXAZOLIDINE-4-YL-METHYL)-1H-INDO- -LE-3-YL)-ETHYLAMINE, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR SOLVATE, METHOD OF ITS SYNTHESIS, DRUG USED AS AN AGONIST OF "5-HT-LIKE" RECEPTOR IN MAMMALS, METHOD OF DRUG AGENT PREPARING |
1991 |
- Alan Dunkan Robertson[Gb]
- Alan Piter Khill[Gb]
- Robert Cherl'Z Glen[Gb]
- Grehm Richard Martin[Gb]
|
RU2110517C1 |
SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, METHODS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING ANTIVIRAL EFFECT BASED ON THEREOF |
1993 |
- Leroj B.Taunsend
- Dzhon Charl'Z Drehch
- Stiven Spenser Gud
- S'Juzn Mehri Del'Judzh
- Majkl Tolar Martin
|
RU2141952C1 |
APPLICATION OF 5-ETHYNYLURACIL AS AN ACTIVATOR OF URACIL-REDUCTASE, PHARMACEUTICAL COMPOSITION, METHOD FOR ITS OBTAINING, PHARMACEUTICAL COMPOSITION FOR INCREASING THE ACTION OR DECREASING THE TOXICITY OF 5-FLUOURACIL |
1991 |
- Spektor Tomas
- Porter Dehvid Dzhon Timoti
- Rakhim Saad Dzhordzh
|
RU2194511C2 |